Answers are grounded in this paper and cite their sources.
Using natural killer (NK) cells to treat hematopoietic and solid tumors has great promise. Despite their availability from peripheral blood and cord blood, stem cell-derived NK cells provide an "off-the-shelf" solution.
No takes yet. Share an insight, caveat, or question.
Ghaedrahmati et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: